Qing Zuraw's most recent trade in Vor Biopharma Inc was a trade of 218,652 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vor Biopharma Inc | Qing Zuraw | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2025 | 218,652 | 218,652 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Qing Zuraw | Chief Development Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Dec 2025 | 218,652 | 0 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Qing Zuraw | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 4,373,040 | 4,373,040 | - | - | Employee Stock Option (right to buy) | |
| Vor Biopharma Inc | Qing Zuraw | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2025 | 937,080 | 937,080 | - | 0 | Common Stock |